HK1046683A1 - Carbamoyl tetrahydropyridine derivatives. - Google Patents

Carbamoyl tetrahydropyridine derivatives.

Info

Publication number
HK1046683A1
HK1046683A1 HK02108223A HK02108223A HK1046683A1 HK 1046683 A1 HK1046683 A1 HK 1046683A1 HK 02108223 A HK02108223 A HK 02108223A HK 02108223 A HK02108223 A HK 02108223A HK 1046683 A1 HK1046683 A1 HK 1046683A1
Authority
HK
Hong Kong
Prior art keywords
group
atom
alkyl group
derivatives
tetrahydropyridine derivatives
Prior art date
Application number
HK02108223A
Other languages
English (en)
Inventor
Atsuro Nakazato
Taketoshi Okubo
Toshihito Kumagai
Kazuyuki Tomisawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of HK1046683A1 publication Critical patent/HK1046683A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
HK02108223A 1999-03-11 2002-11-13 Carbamoyl tetrahydropyridine derivatives. HK1046683A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6500499 1999-03-11
JP18562899 1999-06-30
JP25835399 1999-09-13
PCT/JP2000/001468 WO2000053604A1 (fr) 1999-03-11 2000-03-10 Derives de carbamoyl tetrahydropyridine

Publications (1)

Publication Number Publication Date
HK1046683A1 true HK1046683A1 (en) 2003-01-24

Family

ID=27298632

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108223A HK1046683A1 (en) 1999-03-11 2002-11-13 Carbamoyl tetrahydropyridine derivatives.

Country Status (11)

Country Link
US (2) US6600038B1 (fr)
EP (2) EP1449843A1 (fr)
KR (1) KR20010102544A (fr)
CN (1) CN1174984C (fr)
AT (1) ATE297393T1 (fr)
AU (1) AU756702B2 (fr)
CA (1) CA2366642A1 (fr)
DE (1) DE60020692T2 (fr)
ES (1) ES2239592T3 (fr)
HK (1) HK1046683A1 (fr)
WO (1) WO2000053604A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028782A1 (es) 2000-07-05 2003-05-21 Taisho Pharmaceutical Co Ltd Derivados heterociclicos tetrahidropiridino o piperidino
WO2004050656A1 (fr) 2002-12-04 2004-06-17 Eisai Co., Ltd. Compose 1,3-dihydro-imidazole a cycle fusionne
AR042667A1 (es) * 2002-12-26 2005-06-29 Taisho Pharmaceutical Co Ltd Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
US7112585B2 (en) 2003-04-18 2006-09-26 Bristol-Myers Squibb Company Pyrimidine derivatives as corticotropin releasing factor inhibitors
US7030145B2 (en) 2003-04-18 2006-04-18 Bristol-Myers Squibb Company Pyridinyl derivatives for the treatment of depression
RU2006128580A (ru) * 2004-01-06 2008-02-20 Тайсо Фармасьютикал Ко., Лтд. (Jp) Производные тиенопиримидина и тиенопиридина, замещенные циклической аминогруппой
ATE356129T1 (de) 2004-01-06 2007-03-15 Taisho Pharmaceutical Co Ltd Triazacyclopenta(cd)indenderivate
CA2552503C (fr) * 2004-01-06 2011-09-13 Taisho Pharmaceutical Co., Ltd. Derives de pyrrolopyrimidine et de pyrrolotriazine
JP2007526906A (ja) * 2004-03-05 2007-09-20 大正製薬株式会社 ピロロピリミジン誘導体
MXPA06015002A (es) * 2004-06-25 2007-02-08 Taisho Pharma Co Ltd Derivados de pirrolopirimidina y pirrolopiridina sustituidos con tetrahidropiridina como antagonistas de crf.
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
WO2006073610A2 (fr) * 2004-11-23 2006-07-13 Reddy Us Therapeutics, Inc. Nouveaux composes bicycliques heterocycliques, leur procede de preparation et compositions les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2818676A1 (de) * 1978-04-27 1979-11-08 Troponwerke Gmbh & Co Kg Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO1994013676A1 (fr) 1992-12-17 1994-06-23 Pfizer Inc. Pyrrolopyrimidines en tant qu'antagonistes du facteur liberateur de corticotrophine (crf)
US6187781B1 (en) * 1997-03-26 2001-02-13 Taisho Pharmaceutical Co., Ltd. 4-Tetrahydropyridylpyrimidine derivatives
JPH11335376A (ja) 1998-05-25 1999-12-07 Taisho Pharmaceut Co Ltd アリールテトラヒドロピリジン誘導体
JP2000086663A (ja) * 1998-09-09 2000-03-28 Taisho Pharmaceut Co Ltd アリールテトラヒドロピリジン誘導体

Also Published As

Publication number Publication date
EP1176146A1 (fr) 2002-01-30
ES2239592T3 (es) 2005-10-01
CN1174984C (zh) 2004-11-10
CA2366642A1 (fr) 2000-09-14
US20030191122A1 (en) 2003-10-09
KR20010102544A (ko) 2001-11-15
ATE297393T1 (de) 2005-06-15
DE60020692D1 (de) 2005-07-14
US6600038B1 (en) 2003-07-29
AU2941400A (en) 2000-09-28
EP1449843A1 (fr) 2004-08-25
EP1176146A4 (fr) 2003-07-09
WO2000053604A1 (fr) 2000-09-14
DE60020692T2 (de) 2006-03-23
US6894168B2 (en) 2005-05-17
EP1176146B1 (fr) 2005-06-08
CN1350536A (zh) 2002-05-22
AU756702B2 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
GB9722520D0 (en) Compounds
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
WO2006005609A3 (fr) Derives d'oxindole substitues, et medicaments les renfermant
AU1282495A (en) Anthranilic acid derivative
HK1046683A1 (en) Carbamoyl tetrahydropyridine derivatives.
PT718293E (pt) Composto ciclodepsipeptidico
ATE452882T1 (de) Herstellung von quetiapin
ATE201195T1 (de) Tricyclische verbindungen
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
NO20062202L (no) Amidometylsubstituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater, fremgangsmate og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene
EP0903347A4 (fr)
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
DE69214127D1 (de) Überbrückte, cyclische ketale
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
MXPA04007048A (es) Derivados de amidoacetonitrilo.
HU9501466D0 (en) Glycopyranoside benzothiophenes
AU2002364711A1 (en) Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
DE50001717D1 (en) Herbizide substituierte thienocycloalk(en)ylamino-1,3,5-triazine
GB0309440D0 (en) Quinolone derivatives
EP1557407A4 (fr) Nouveau derive alpha-cetoamide et son utilisation
ZA200400824B (en) Pyridin-2-yl-methlyamine derivatives for treating opioid dependence.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090310